Webcast ImageWebcast
Neos Therapeutics at JMP Securities Life Sciences Conference (Replay)
06/21/17 at 9:30 a.m. ET
Neos Therapeutics at JMP Securities Life Sciences Conference
Wednesday, June 21, 2017 9:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Corporate Profile

Neos Therapeutics is focused on developing, manufacturing and commercializing branded products utilizing our proprietary extended-release drug delivery technology platform. We have used this technology to develop our three product candidates being investigated for the treatment of attention deficit hyperactivity disorder, or ADHD. Our ADHD product candidates are extended-release, or XR, medications in patient-friendly, orally disintegrating tablets, or ODT, or liquid suspension dosage forms.

News Releases